Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.125 AUD | -0.88% | -2.17% | -23.47% |
Valuation
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 447.4 | 740.1 | 636.1 | - | - |
Enterprise Value (EV) 1 | 467 | 1,436 | 1,085 | 1,099 | 1,117 |
P/E ratio | - | - | - | - | - |
Yield | 5.45% | 5.8% | 7.13% | 7.33% | 7.85% |
Capitalization / Revenue | 15.4 x | 15.5 x | 9.65 x | 9.37 x | 8.96 x |
EV / Revenue | 16 x | 30.1 x | 16.5 x | 16.2 x | 15.7 x |
EV / EBITDA | 24.5 x | 48.5 x | 17.7 x | 17.5 x | 16.8 x |
EV / FCF | 19.8 x | 63.3 x | 50.2 x | 36.7 x | 20.5 x |
FCF Yield | 5.05% | 1.58% | 1.99% | 2.72% | 4.89% |
Price to Book | 0.68 x | 0.78 x | 0.66 x | 0.65 x | 0.64 x |
Nbr of stocks (in thousands) | 325,378 | 562,814 | 565,385 | - | - |
Reference price 2 | 1.375 | 1.315 | 1.125 | 1.125 | 1.125 |
Announcement Date | 8/11/22 | 8/14/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 29.14 | 47.7 | 65.89 | 67.9 | 71 |
EBITDA 1 | 19.1 | 29.6 | 61.15 | 62.81 | 66.53 |
EBIT 1 | 17.47 | 29.6 | 62.34 | 64.96 | 67.91 |
Operating Margin | 59.94% | 62.05% | 94.61% | 95.66% | 95.65% |
Earnings before Tax (EBT) | 49.61 | - | - | - | - |
Net income | - | 20.2 | - | - | - |
Net margin | - | 42.35% | - | - | - |
EPS | - | - | - | - | - |
Free Cash Flow 1 | 23.59 | 22.7 | 21.6 | 29.9 | 54.6 |
FCF margin | 80.95% | 47.59% | 32.78% | 44.04% | 76.9% |
FCF Conversion (EBITDA) | 123.49% | 76.69% | 35.32% | 47.6% | 82.07% |
FCF Conversion (Net income) | - | 112.38% | - | - | - |
Dividend per Share 2 | 0.0750 | 0.0762 | 0.0802 | 0.0824 | 0.0883 |
Announcement Date | 8/11/22 | 8/14/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 |
---|---|---|---|---|---|
Net sales 1 | 10.84 | 18.29 | - | - | 39.6 |
EBITDA 1 | - | - | - | 18.4 | 29.1 |
EBIT 1 | 4.423 | 11.39 | 10.6 | 18.4 | 29.1 |
Operating Margin | 40.79% | 62.25% | - | - | 73.48% |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income | - | - | 1.542 | - | - |
Net margin | - | - | - | - | - |
EPS | - | - | 0.004700 | - | - |
Dividend per Share | - | - | - | 0.0388 | - |
Announcement Date | 2/17/22 | 8/11/22 | 2/16/23 | 8/14/23 | 2/12/24 |
Balance Sheet Analysis
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | 19.6 | 696 | 449 | 463 | 481 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.026 x | 23.52 x | 7.347 x | 7.364 x | 7.235 x |
Free Cash Flow 1 | 23.6 | 22.7 | 21.6 | 29.9 | 54.6 |
ROE (net income / shareholders' equity) | 2.42% | 2.52% | 4.73% | 4.94% | 5.16% |
ROA (Net income/ Total Assets) | - | 1.67% | 2.44% | 3.11% | 3.86% |
Assets | - | 1,209 | - | - | - |
Book Value Per Share 2 | 2.010 | 1.690 | 1.700 | 1.730 | 1.760 |
Cash Flow per Share 2 | 0.0700 | 0.0600 | 0.0400 | 0.0700 | 0.0800 |
Capex 1 | - | - | - | 1 | 2 |
Capex / Sales | - | - | - | 1.47% | 2.82% |
Announcement Date | 8/11/22 | 8/14/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.47% | 422M | |
+14.97% | 61.99B | |
+0.84% | 20.31B | |
+5.45% | 7.99B | |
-9.17% | 6.14B | |
+14.32% | 3.63B | |
+2.24% | 3.38B | |
-6.13% | 3.08B | |
+9.16% | 3.22B | |
+18.32% | 2.87B |
- Stock Market
- Equities
- HCW Stock
- Financials HealthCo Healthcare and Wellness REIT